{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:41:39Z","timestamp":1791862899138,"version":"4.3.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065158","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T21:18:31Z","timestamp":1370553511000},"page":"e65158","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":91,"title":["ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis"],"prefix":"10.1371","volume":"8","author":[{"given":"Takafumi","family":"Kuroda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hirohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Torigoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyo","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Mariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Mizuuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"KR Cho","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"TJ Perren","year":"2011","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/GRF.0b013e3182480523","article-title":"Symptoms associated with ovarian cancer","volume":"55","author":"B Goff","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"RC Bast Jr","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"MK Parmar","year":"2003","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa1105535","article-title":"Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer","volume":"366","author":"J Ledermann","year":"2012","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"T Reya","year":"2001","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"JE Visvader","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4161\/onci.1.1.18075","article-title":"Cytotoxic T lymphocytes: Sniping cancer stem cells","volume":"1","author":"Y Hirohashi","year":"2012","journal-title":"Oncoimmunology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"M Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1158\/0008-5472.CAN-07-0895","article-title":"Cancer stem cells in radiation resistance","volume":"67","author":"JN Rich","year":"2007","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/imt.10.10","article-title":"Immune response against tumor antigens expressed on human cancer stem-like cells\/tumor-initiating cells","volume":"2","author":"Y Hirohashi","year":"2010","journal-title":"Immunotherapy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"M Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"SK Singh","year":"2004","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"S Zhang","year":"2008","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2011.11.050","article-title":"Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis","volume":"148","author":"WC Zhang","year":"2012","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"MA Goodell","year":"1996","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/labinvest.2011.140","article-title":"SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity","volume":"91","author":"M Nakatsugawa","year":"2011","journal-title":"Lab Invest"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Gangavarpu KJ, Huss WJ (2011) Isolation and applications of prostate side population cells based on dye cycle violet efflux. Curr Protoc Toxicol Chapter 22: Unit 22 22.","DOI":"10.1002\/0471140856.tx2202s47"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"C Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","article-title":"Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis","volume":"69","author":"EH Huang","year":"2009","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.juro.2012.02.2555","article-title":"Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay","volume":"188","author":"S Nishida","year":"2012","journal-title":"J Urol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e10277","DOI":"10.1371\/journal.pone.0010277","article-title":"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers","volume":"5","author":"S Deng","year":"2010","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival","volume":"71","author":"IA Silva","year":"2011","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajpath.2011.11.015","article-title":"ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome","volume":"180","author":"YC Wang","year":"2012","journal-title":"Am J Pathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/modpathol.2009.35","article-title":"ALDH1 expression correlates with favorable prognosis in ovarian cancers","volume":"22","author":"B Chang","year":"2009","journal-title":"Mod Pathol"},{"key":"ref27","first-page":"888","article-title":"Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary","volume":"41","author":"H Yabushita","year":"1989","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"ref28","first-page":"831","article-title":"Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma","volume":"39","author":"I Ishiwata","year":"1987","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Kobayashi S, Yamada-Okabe H, Suzuki M, Natori O, Kato A, <etal>et al<\/etal>.. (2012) LGR5-Positive Colon Cancer Stem Cells Interconvert with Drug Resistant LGR5-Negative Cells and are Capable of Tumor Reconstitution. Stem Cells.","DOI":"10.1002\/stem.1257"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, <etal>et al<\/etal>.. (2012) Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract. Mod Pathol.","DOI":"10.1038\/modpathol.2012.139"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1440-1827.2012.02851.x","article-title":"High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis","volume":"62","author":"Y Michifuri","year":"2012","journal-title":"Pathol Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"PP Szotek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e29079","DOI":"10.1371\/journal.pone.0029079","article-title":"Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer","volume":"7","author":"V Vathipadiekal","year":"2012","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 expression defines a tumor initiating cell population in primary human ovarian cancer","volume":"27","author":"MD Curley","year":"2009","journal-title":"Stem Cells"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00018-010-0420-9","article-title":"Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line","volume":"67","author":"MF Shi","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"MQ Gao","year":"2010","journal-title":"Oncogene"},{"key":"ref37","first-page":"2111","article-title":"CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors","volume":"118","author":"SV Shmelkov","year":"2008","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/path.2307","article-title":"Side populations of gastrointestinal cancers are not enriched in stem cells","volume":"214","author":"J Burkert","year":"2008","journal-title":"J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers","volume":"109","author":"JK Chan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3802\/jgo.2013.24.1.37","article-title":"Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review","volume":"24","author":"M Miyamoto","year":"2013","journal-title":"J Gynecol Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:30:40Z","timestamp":1645684240000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065158"}},"subtitle":[],"editor":[{"given":"Xin-Yuan","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,6]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065158","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,6]]}}}